Literature DB >> 6084346

Effect of gossypol on liver metabolic enzymes in male rats.

S F Ali, S M El-Sewedy.   

Abstract

The effects of gossypol on liver metabolism were examined in male rats. Gossypol acetic acid was administered to Sprague-Dawley rats intraperitoneally (i.p.) at 5 mg/kg daily, 5 days/week for 2 weeks. The rats were killed 24 h after the last injection. The liver/body weight ratio (-42%), concentration of liver glutathione (-34%), activities of liver alpha-naphthtylacetate esterase (-30%) and DNase (-39%) were significantly decreased when compared to controls. Hepatic beta-glucuronidase (+37%), RNase (+35%) and serum alkaline RNase (+23%) activities were significantly increased. No changes were found in serum transaminases (SGPT, SGOT) or in hepatic RNA and DNA concentration. Elevation of liver and serum RNase activities suggest that gossypol treatment produces some catabolic effects. The depletion of hepatic glutathione and the elevation of beta-glucuronidase activity indicate that gossypol is hepatotoxic when given at this dose for 2 weeks.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6084346     DOI: 10.1016/0378-4274(84)90025-0

Source DB:  PubMed          Journal:  Toxicol Lett        ISSN: 0378-4274            Impact factor:   4.372


  3 in total

1.  Effect of gossypol on hepatic and serum gamma-glutamyltransferase activity in rats.

Authors:  D P Deoras; P Young-Curtis; R R Dalvi; F E Tippett
Journal:  Vet Res Commun       Date:  1997-07       Impact factor: 2.459

2.  Double-layered hyaluronic acid/stearic acid-modified polyethyleneimine nanoparticles encapsulating (-)-gossypol: a nanocarrier for chiral anticancer drugs.

Authors:  Hao Liu; Ke Li; Lan Lan; Jingwen Ma; Yun Zeng; Liang Xu; Daocheng Wu
Journal:  J Mater Chem B       Date:  2014-08-28       Impact factor: 6.331

Review 3.  Systematic Review of Gossypol/AT-101 in Cancer Clinical Trials.

Authors:  Olga Renner; Mascha Mayer; Christian Leischner; Markus Burkard; Alexander Berger; Ulrich M Lauer; Sascha Venturelli; Stephan C Bischoff
Journal:  Pharmaceuticals (Basel)       Date:  2022-01-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.